Conjugating Existing Clinical Drugs With Gold Nanoparticles for Better Treatment of Heart Diseases
Developing new methods to treat heart diseases is always a focus for basic research and clinical applications. Existing drugs have strong side-effects and also require lifetime administration for patients. Recent attempts of using nanoparticles (NPs) in treating atherosclerosis in animals and some h...
Main Authors: | Jingwen Zhang, Aiqun Ma, Lijun Shang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphys.2018.00642/full |
Similar Items
-
The effect of phospho-peptide on the stability of gold nanoparticles and drug delivery
by: Zhanwu Hou, et al.
Published: (2019-08-01) -
Gold Nanoparticles as Drug Carriers: The Role of Silica and PEG as Surface Coatings in Optimizing Drug Loading
by: José Luis Carreón González, et al.
Published: (2023-02-01) -
Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells
by: Kalishwaralal Kalimuthu, et al.
Published: (2018-03-01) -
A review of small molecules and drug delivery applications using gold and iron nanoparticles
by: Jahangirian H, et al.
Published: (2019-03-01) -
Gold Nanoparticles: Construction for Drug Delivery and Application in Cancer Immunotherapy
by: Huiqun Huang, et al.
Published: (2023-07-01)